Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
05/2003
05/15/2003WO2002026987A3 A human g-protein coupled receptor, hgprbmy6, expressed highly in small intestine
05/15/2003WO2002026781A9 Ige receptor antagonists
05/15/2003WO2002026717A8 Hydroxy acid integrin antagonists
05/15/2003WO2002000611A8 Fmoc-l-leucine and derivatives thereof as ppar-gamma agonists
05/15/2003WO2001079173A3 Enamine derivatives as cell adhesion molecules
05/15/2003US20030092908 Autoimmune diseases; rheumatic diseases; multiple sclerosis; inflammatory bowel disease; immunosuppressants
05/15/2003US20030092771 Inhibitors of transcription factor NF-kappaB
05/15/2003US20030092765 Irritable bowel disorders; infections of intestine
05/15/2003US20030092762 Anti-inflammatory nitro and thia-fatty acids
05/15/2003US20030092744 Novel compounds for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof
05/15/2003US20030092736 Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method
05/15/2003US20030092732 Eating disorders; dietetics; antiinflammatory agents; autoimmune diseases
05/15/2003US20030092728 Antagonists of MCP-1 function and methods of use thereof
05/15/2003US20030092727 Hydroxamic and carboxylic acid derivatives
05/15/2003US20030092721 Antiinflammatory agents; rheumatic diseases
05/15/2003US20030092717 Inhibitors of p38 kinase
05/15/2003US20030092714 Heterocyclic inhibitors of ERK2 and uses thereof
05/15/2003US20030092713 Antiinflammatory agents; antiallergens; psychological disorders
05/15/2003US20030092712 Antiinflammatory agents; rheumatic diseases
05/15/2003US20030092704 Novel arylglycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
05/15/2003US20030092703 Caspase inhibitors and uses thereof
05/15/2003US20030092702 Antiinflammatory agents; autoimmune disease; autoimmune diseases
05/15/2003US20030092697 Antidiabetic, antilipemic agents; cardiovascular disorders; anticancer agents
05/15/2003US20030092678 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases
05/15/2003US20030092677 Glutamate receptor antagonists
05/15/2003US20030092642 Diphosphate salt of a 4" -substituted-9-deoxo-9A-AZA-9A-homoerythromycin derivative and its pharmaceutical composition
05/15/2003US20030092633 Preventing desensitization of receptors
05/15/2003US20030092630 Amino acid side chain-modified substrates of the enzyme; obtaining locally limited inhibition; treating inflammation, psoriasis, periodontitis, allergies, arthritis, tumors or autoimmune diseases
05/15/2003US20030092176 Ependymal neural stem cells and method for their isolation
05/15/2003US20030092163 Probiotic bifidobacterium strains
05/15/2003US20030092080 Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC pANCA antigens
05/15/2003US20030092059 Human antibodies that bind human TNFalpha
05/15/2003US20030092054 Protein complexes and assays for screening anti-cancer agents
05/15/2003US20030092030 Wit 3.0, a novel gene to control soft tissue wound healing
05/15/2003US20030091974 Detecting compounds capable of exhausting mast cells; culture mast cells, incubate with modulator, measure mast cell death, classify compound
05/15/2003US20030091668 Process and composition for controlling fecal hair excretion and trichobezoar formation
05/15/2003US20030091651 Oil homogenized with sterols; protective coating for stomach
05/15/2003US20030091635 Sustained release; reduced tendency to drug abruse
05/15/2003US20030091630 Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
05/15/2003US20030091620 Transdermal drug delivery systems containing quaternary ammonium salts and methods of using the same
05/15/2003US20030091555 Sterilizing food poison bacteria using ethylenediamine, or salt thereof as chelate compound
05/15/2003US20030091553 Use of histamine to treat liver disease
05/15/2003US20030091549 Antiinflammatory agents; inflammatory bowel disease; gastrointestinal disorders
05/15/2003US20030091517 Andrographis paniculata gel as an adjunct in the treatment of periodontitis
05/15/2003US20030090017 Manikin and eye device apparatus, methods and articles of manufacture
05/15/2003CA2669810A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase
05/15/2003CA2467853A1 Antibody stimulating il-1ra production
05/15/2003CA2466278A1 Rehydrating formulation
05/15/2003CA2466232A1 Systems for delivery and release of angiotensin-(1-7)
05/15/2003CA2466198A1 Somatic cell derived embryonic stem cells and their differentiated progenies
05/15/2003CA2466061A1 Oral adhering and dissolving disc made by deposition with licorice extract
05/15/2003CA2466030A1 Intraorally disintegrating valdecoxib compositions prepared by fluid bed granulation process
05/15/2003CA2466022A1 Probiotic compositions
05/15/2003CA2465981A1 Antigen arrays comprising rankl for treatment of bone disease
05/15/2003CA2465948A1 A method for treating inflammatory bowel disease
05/15/2003CA2465945A1 Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
05/15/2003CA2465894A1 Method for treating or preventing inflammatory diseases
05/15/2003CA2465731A1 Screening for hepatitis c virus entry inhibitors
05/15/2003CA2465711A1 Aminopyrimidines and pyridines
05/15/2003CA2465700A1 Solid oral compositions
05/15/2003CA2465695A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase
05/15/2003CA2465239A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/15/2003CA2465159A1 Process for preparing quick dissolving, high loading ribavirin compositions
05/15/2003CA2464717A1 Compounds and methods for treating transplant rejection
05/15/2003CA2464685A1 Novel mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (asbt) and taurocholate uptake
05/15/2003CA2464614A1 Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides
05/15/2003CA2464528A1 Pharmaceutical composition
05/15/2003CA2464470A1 Novel epidermal growth factor protein and gene, and methods of use therefor
05/14/2003EP1310571A2 A Method of detecting and/or identifying adeno-associated virus (AVV) sequences and isolating novel sequences identified thereby
05/14/2003EP1310505A1 Amine salt of lignan compound
05/14/2003EP1310498A2 Pyrazoloquinolinone derivatives as protein kinase C inhibitors
05/14/2003EP1310493A1 N-adamantylalkyl benzamide derivates as p2x7-receptor antagonists
05/14/2003EP1310252A1 Injections
05/14/2003EP1309706A2 Modulation of stem cell differentiation
05/14/2003EP1309703A2 Kallikrein gene
05/14/2003EP1309697A2 Regulation of human 11 beta-hydroxysteroid dehydrogenase 1-like enzyme
05/14/2003EP1309684A2 Polynucleotides and polypeptides encoded thereby
05/14/2003EP1309618A2 Leucine-based motif and clostridial neurotoxins
05/14/2003EP1309609A2 Lactam compounds and their use as inhibitors of serine proteases and method
05/14/2003EP1309605A1 Prodrugs of betulinic acid derivatives for the treatment of cancer and hiv
05/14/2003EP1309596A2 Heterocyclic compounds useful as inhibitors of tyrosine kinases
05/14/2003EP1309594A1 Benzimidazole derivatives, preparation and therapeutic use thereof
05/14/2003EP1309589A2 Urea compounds and methods of uses
05/14/2003EP1309575A1 Biphenyl derivatives and their use as ppar-gamma receptor activators
05/14/2003EP1309571A1 Non-steroidal inflammation inhibitors
05/14/2003EP1309566A1 Dihydroxypyrimidine carboxylic acids as viral polymerase inhibitors
05/14/2003EP1309560A1 Pyridine derivatives as inhibitors of p38
05/14/2003EP1309559A1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
05/14/2003EP1309552A1 Compounds and inhibitors of phospholipases
05/14/2003EP1309551A1 Indoline derivatives as 5ht2c antagonists
05/14/2003EP1309373A2 Method and composition for altering a t cell mediated pathology
05/14/2003EP1309354A2 Therapeutic polyesters and polyamides
05/14/2003EP1309347A2 Method and composition for altering a b cell mediated pathology
05/14/2003EP1309334A2 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
05/14/2003EP1309328A1 Cox-2 inhibitors and the prevention of the side effects of radiation therapy
05/14/2003EP1309325A1 Anticonvulsant derivatives useful for the treatment of depression
05/14/2003EP1309316A2 Oral fast-melt dosage form of a cyclooxygenase-2 inhibitor
05/14/2003EP1278743A4 Novel anti-infectives
05/14/2003EP1180105B1 Substituted aza-oxindole derivatives
05/14/2003EP1175157A4 Low molecular weight polymannuronate
1 ... 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 ... 1258